IN2013MU03565A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03565A
IN2013MU03565A IN3565MU2013A IN2013MU03565A IN 2013MU03565 A IN2013MU03565 A IN 2013MU03565A IN 3565MU2013 A IN3565MU2013 A IN 3565MU2013A IN 2013MU03565 A IN2013MU03565 A IN 2013MU03565A
Authority
IN
India
Prior art keywords
processes
preparation
lorcaserin
relates
solvates
Prior art date
Application number
Inventor
Shri Prakash Dhar Dwivedi
Jayprakash Ajitsingh Parihar
Alpeshkumar Pravinchandra Shah
Samir Rameshbhai Gajjar
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Priority to US15/035,876 priority Critical patent/US9714225B2/en
Priority to IN3565MU2013 priority patent/IN2013MU03565A/en
Priority to PCT/IN2014/000718 priority patent/WO2015102017A1/en
Publication of IN2013MU03565A publication Critical patent/IN2013MU03565A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

ABSTRACT “PROCESSES FOR THE PREPARATION OF LORCASERIN” The present invention relates to stable crystalline Form I of lorcaserin hydrochloride of Formula (IA) and processes for its preparation. The invention also relates to processes for the preparation of lorcaserin and pharmaceutically acceptable salts, solvates and hydrates thereof. (IA)
IN3565MU2013 2013-11-13 2014-11-13 IN2013MU03565A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US15/035,876 US9714225B2 (en) 2013-11-13 2014-11-13 Processes for the preparation of lorcaserin
IN3565MU2013 IN2013MU03565A (en) 2013-11-13 2014-11-13
PCT/IN2014/000718 WO2015102017A1 (en) 2013-11-13 2014-11-13 Processes for the preparation of lorcaserin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3565MU2013 IN2013MU03565A (en) 2013-11-13 2014-11-13

Publications (1)

Publication Number Publication Date
IN2013MU03565A true IN2013MU03565A (en) 2015-07-24

Family

ID=52785144

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3565MU2013 IN2013MU03565A (en) 2013-11-13 2014-11-13

Country Status (3)

Country Link
US (1) US9714225B2 (en)
IN (1) IN2013MU03565A (en)
WO (1) WO2015102017A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105924396B (en) * 2015-12-18 2018-08-21 重庆两江药物研发中心有限公司 A kind of preparation method of green card color woods
CN106389377A (en) * 2016-08-31 2017-02-15 安徽省润生医药股份有限公司 Lorcaserin hydrochloride capsule and preparation process thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101281919B1 (en) * 2004-12-21 2013-07-03 아레나 파마슈티칼스, 인크. Crystalline forms of (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
EP2001852A2 (en) * 2006-04-03 2008-12-17 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
CA2670285A1 (en) * 2006-12-05 2008-06-12 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
US8399011B1 (en) * 2012-08-10 2013-03-19 Magnifica Inc. Oral particle compositions containing a core and an acid-soluble coat

Also Published As

Publication number Publication date
WO2015102017A1 (en) 2015-07-09
US20160280658A1 (en) 2016-09-29
WO2015102017A8 (en) 2015-08-27
US9714225B2 (en) 2017-07-25

Similar Documents

Publication Publication Date Title
PH12017500408A1 (en) Heteroaryl compunds as btk inhibitors and uses thereof
PH12016500467B1 (en) Aminoheteroarlyl benzamides as kinase inhibitors
MX2016011992A (en) Piperidine-dione derivatives.
PH12015501996B1 (en) Heterocyclic compounds and uses thereof
PH12015502031B1 (en) Tetrahydropyrrolothiazine compounds
PH12015501363B1 (en) Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity
MY176803A (en) Polymorph of syk inhibitors
MY197698A (en) Oxysterols and methods of use thereof
PH12015501588B1 (en) Compounds and methods for treating bacterial infections
PH12015502118A1 (en) Pyridin-4-yl derivatives
JO3318B1 (en) Bace inhibitors
IN2013MU03862A (en)
AU2015292632B2 (en) Aldosterone synthase inhibitors
IN2013MU03565A (en)
IN2013MU04056A (en)
PH12016500809A1 (en) Glucopyranosyl - substituted indole-urea derivatives and their use as sglt inhibitors
IN2013CH04314A (en)
IN2013MU03422A (en)
IN2013MU03308A (en)
IN2013MU03309A (en)
IN2013MU02010A (en)
IN2013MU01226A (en)
MX2017005669A (en) Benzylhydroxyde derivatives, preparation thereof and therapeutic use thereof.
IN2013CH04981A (en)
IN2013MU01160A (en)